The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership
1.4.2026 09:00:00 CEST | Business Wire | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks
The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June.
Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI.
The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions.
“Through our work we increasingly see that the central challenge of AI adoption is not technical capability alone, but organisational readiness, leadership alignment, and responsible implementation,” said Keyvan Vakili, Associate Professor, Strategy & Entrepreneurship, London Business School. “Success with AI depends on how organisations and leaders adapt, how they redesign organisational processes, align decision-making, manage stakeholders, and build the structures needed to deploy and scale these systems effectively.”
The track for practitioners and more general users of AI,Mastering AI: From Prompts to Agents led by General Purpose, a UK AI enablement and training company, operates as a hands-on technical workshop designed to take business professionals of varying backgrounds from confident AI assistant user to capable agent builder in a single day, underscoring the continued evolution of The AI Summit London as a forum where insight meets implementation.
“As artificial intelligence assumes a central role in shaping enterprise strategy, the need for informed, capable leadership has never been more pronounced,” said Rory Crone, Senior Marketing Director, The AI Summit Series. “Through our new partnerships with London Business School and General Purpose, the new programmes provide a platform for successful AI adoption that hinges not only on technology, but on executive acumen, strategic integration, and organisational readiness.”
Part of the expanded Summit’s 2026 offering, the bespoke training will take place at Studio Spaces located across from Tobacco Dock and offers a focused learning environment tailored to decision makers seeking to translate artificial intelligence from concept into commercial impact.
10 Stages. 14 Tracks. Zero Fluff.
Attendees holding the Tobacco Dock Campus Pass gain access to the Headliners Stage, The AI Trail, The Quayside Networking Lounge, Start-Up & Investor Village, Creative AI Stage, AI Demo Tours and more than 100 immersive exhibitions showcasing the future of technology. All other passes will have access to additional conference tracks and programming, including:
- Next Generation Track: Focusing on the development of forward-thinking applications, infrastructure and hardware.
- Beyond AI at Scale Track: Covering critical topics like responsible AI governance, strategic scaling, and balancing innovation with regulation.
- Industrial AI Track: Focusing on adopting AI in manufacturing, energy, utilities, transportation, aerospace, defence, and other regulated and mission-critical industries.
- Data Excellence Track: Focusing on stabilising and scaling AI systems by addressing data-related challenges such as fragile data foundations, pipeline failures, governance issues, and maintaining trust in enterprise-scale environments.
- Finance Track: Reviewing the impact of generative AI, safeguarding digital integrity, ethical development, and celebrating female leaders in the financial services field.
- Creative AI Track: Showcasing the groundbreaking influence of generative tools in film, design, music, marketing, and interactive media, with sessions covering new production workflows, IP protection, human–AI collaboration, and the future of creative work and storytelling.
- Science Track: For healthcare and life sciences, AI is no longer experimental, it’s transforming how breakthroughs happen, and the Science Track will showcase how organisations harness AI to accelerate research, validate results with confidence, and turn data into real-world patient impact.
- AI Cybersecurity Track: Focusing on the rapidly changing threat landscape with in-depth sessions on AI-powered defense, red-teaming, identity protection, SecOps automation, threat intelligence, and protecting enterprises against both AI-enabled attacks and model-specific vulnerabilities.
- Start-Up & Investor Track: Hear from leading venture capitalists on what sets successful AI start-ups apart, why some thrive while others don’t, and catch Day 2 of the Start-Up Pitching Competition to see the next generation of AI innovators in action.
The 10th edition of The AI Summit London is presented in part by sponsors IBM, Glean, Nebius, Elsewhen, DX, Hewlett Packard Enterprise & NVIDIA, EY, Amazon Web Services, EverWorker, Italian Trade Agency, NiCE, CoreWeave, Make, Red Hat, Reflection AI, Tricentis, and World Wide Technology.
Delegates have options when attending The AI Summit London with new and existing travel offers from partners Delta Airlines, United Airlines, Eurostar and HotelMap.
To register for the 2026 show running 10-11 June, visit www.london.theaisummit.com. Early Bird pricing ends 23 April. Interested members of the press and analysts may register here to attend.
ABOUT THE AI SUMMIT LONDON
The AI Summit London is the UK and Europe’s leading event for applied artificial intelligence, bringing together forward-thinking technologists, business leaders and policymakers from around the world to explore how AI is being deployed at scale across enterprise.
Taking place at Tobacco Dock on 10–11 June 2026, the Summit marks its 10th anniversary, celebrating a decade of progress in commercial AI. Over two days, the event delivers an immersive experience combining strategic insight, practical use cases and live technology demonstrations, empowering organisations to move confidently from experimentation to real-world impact.
As the flagship AI event of London Tech Week, The AI Summit London provides unparalleled opportunities for AI adopters to connect with peers, partners and innovators, equipping them with the knowledge, tools and relationships needed to accelerate responsible, results-driven AI initiatives.
ABOUT THE AI SUMMIT SERIES
If you’re building, buying or backing AI, The AI Summit Series is where ideas become outcomes. We cut through the buzzwords to spotlight real use cases, live demos and candid playbooks that help you deploy faster, govern smarter and prove ROI with confidence. No hype, just AI that transforms business.
Launched by Informa in 2016, at a time when artificial intelligence events were largely focused on research and academia, The AI Summit Series was the first conference and exhibition dedicated to what AI means in practice for business.
For a decade, the Series has convened senior executives, investors, technology providers and data scientists to share insight, showcase breakthrough solutions and shape the commercial AI ecosystem. Trusted long before the hype, The AI Summit has established itself at the centre of the global AI community.
Today, the Series delivers world-class events across London, New York, Singapore, and Melbourne continuing to set the standard for enterprise-focused, responsible AI worldwide.
For more information, visit www.london.theaisummit.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260401394461/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press release
From dating apps to financial details, respondents report seeing a wide range of highly personal information on others' screens 56% of people admit to having looked at strangers’ phone screens accidentally, whereas 24% have done so out of curiosity. 57% identify public transport as the most likely place to notice someone else's screen. While 48%* feel confident they can keep their phone activity private when using it in crowded places, another 52%** acknowledge it is easy to see someone’s screen who is next to you in a public place without trying to look. 33% say they have seen personal content on a stranger’s phone in public. Some smartphone users who have looked at a stranger’s phone screen in public ignore and continue what they were doing (28%) or look away immediately (27%), but others (7%) admit to continuing to look discreetly. The new Samsung Galaxy S26 Privacy Display1 limits side-angle viewing of your screen to protect your privacy in any setting. As millions of Europeans2 ge
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom